Most tumors contain regions of low oxygen concentration where cancer therapies based on the action of reactive oxygen species are ineffective. Now, American scientists have developed a hybrid nanomaterial that releases a free-radical-generating prodrug inside tumor cells upon thermal activation. As they report in the journal Angewandte Chemie, the free radicals destroy the cell components even in oxygen-depleted conditions, causing apoptosis. Delivery, release, and action of the hybrid material can be precisely controlled.
Many well-established cancer treatment schemes are based on the generation of reactive oxygen species (ROS), which induce apoptosis for the tumor cells. However, this mechanism only works in the presence of oxygen, and hypoxic (oxygen-depleted) regions in the tumor tissue often survive the ROS-based treatment. Therefore, Younan Xia at the Georgia Institute of Technology and Emory University, Atlanta, USA, and his team have developed a strategy to deliver and release a radical-generating prodrug that, upon activation, damages cells by a ROS-type radical mechanism, but without the need for oxygen.
The authors explained that they had to turn to the field of polymerization chemistry to find a compound that produces enough radicals. There, the azo compound AIPH is a well-known polymerization initiator. In medicinal applications, it generates free alkyl radicals that cause DNA damage and lipid and protein peroxidation in cells even under hypoxic conditions. However, the AIPH must be safely delivered to the cells in the tissue. Thus, the scientists used nanocages, the cavities of which were filled with lauric acid, a so-called phase-change material (PCM) that can serve as a carrier for AIPH. Once inside the target tissue, irradiation by a near-infrared laser heats up the nanocages, causing the PCM to melt and triggering the release and decomposition of AIPH.
Image Credit: Triche National Cancer Institute
News This Week
A small clinical trial using gold nanoparticles that act as tumor-seeking missiles on a mission to remove prostate cancer has begun at The University of Texas Health Science Center at Houston (UTHealth). It [...]
A small clinical trial using gold nanoparticles that act as tumor-seeking missiles on a mission to remove prostate cancer has begun at The University of Texas Health Science Center at Houston (UTHealth). It is [...]
Nanomedical Device and Systems Design: Challenges, Possibilities, Visions now available to rent on Kindle
To accommodate students who wish to read the book at an affordable cost, Nanomedical Device and Systems Design: Challenges, Possibilities, Visions by Frank Boehm (CEO NanoApps Medical Inc.) is available to rent on Kindle. This book benefits [...]
Researchers at the Mount Sinai School of Medicine have developed a new nanotechnology-based immunotherapy that promotes long-term transplant acceptance in an animal model. The development, which is described in the journal Immunity, could transform [...]
“It’s a bit like driving past a vineyard and looking out the window at the vineyard rows. Every now and then, you see no rows because you’re looking directly along a row,” said Nathaniel [...]
The use of nanoparticles and other nanoscale materials has been gathering a lot of significant interest in recent years and has even adapted into its own interdisciplinary field of science known as nanomedicine. Whilst [...]